FDA Approved: MEROPENEM — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for Meropenem by Sandoz Inc, resulting in updated regulatory status for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Infection
• Intra-abdominal Infection
• Meningitis
• Pneumonia
• Skin and Skin Structure Infection

Drugs mentioned

• Meropenem (Meropenem)

Snippet

SUPPL AP for MEROPENEM (MEROPENEM)